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Introduction
Chapter I
Bovine genital trichomoniasis is caused by Tritrichomonas foetus and is
characterized by infertility, early embryonic death, abOl·tion, or reduced calving rates. 2.20
Treatment of the infection is difficult in bulls, although oral dimetridazole23 and
ipronidaxole27 have shown some success. Treatment is not as crucial in cows because the
infection is self-limiting, persisting for up to 95 days.24
Past attempts to produce a vaccine against T. foetus using membrane proteins or
membrane glycoproteins administered in a mineral oil adjuvant met limited success.S•ll
A recently developed Trichomonas foetus vaccine (Fort Dodge Laboratories, Ft. Dodge,
IA) consisting of killed whole cell Tritrichomonas foetus in a dual adjuvant system
formulated to enhance the immune response and the product brochure indicates that
significantly higher titers were produced than with other vaccines.
Herd disease prevention programs seem to be the best methods to control the
parasites. Prevention involves identifying infected animals and either removing them
from the herd or treating them. The most common detection method is by
cultivation/microscopic examinations of prepucial or vaginal washingl-i.:/4 However, these
tests require 3-4 weeks, and not all laboratories perform the tests.
Several serologic methods have been investigated for detection of trichomoniasis.
An ELISA test was developed but exhibited problems with non-specific antigen cross-
reactivity resulting in frequent false-positive results. ~(f However it is possible to detect
specific antibodies, such as IgG and IgA, in serum and seminal plasma using either
ELISA5 or slide IFA methods. 18,27 A DNA hybridization assay was developed and showed
some promise, but the tests require days to run and are too expensive for practical field
1
2application. 1,30
Tritriehomonas foetus does not invade the epithelium of the cow's reproductive
tract, but remains within the lumen or on the mucosal surface.2.~.2t' Because the bovine
reproductive tract is a component of the secretory immune system, local responses to
infection would be expected instead of a systemic response. A study done by Skirrow and
BonDurant attempted to define the isotypes and temporal pattern of specific anti-To
foetus antibodies produced in both the female reproductive tmct and circulation during
an experimental trichomonad infection. They showed evidence of humoral immune
response in all regions of the reproductive tract, and to a lesser extent, in the systemic
circulation.28
Tritrichomonas foet.us colonizes all parts of the reproductive tract of a cow within
two weeks of the initial infection. The numbel"S of parasites in the cervico-vagillal mucus
fluctuates during the estrous cycle, with largest numbers a few days before estrous.
Cows may maintain infection throughout pregnancy and up to six to nine weeks
postpartum, thus serving as a source of possible infecLion for bulls.: t2
The immunoglobulin subclasses in the bovine reproductive tract tend to vary
within different regions of the tract. 21l Corbeil et at. II demonstrated with Campylobaete'"
fetus var uenerialis infections that 19A predominated in the vagina and IgG in the uterus;
this was similarly revealed using Mycoplasma Sp.8 Antibodies of the IgG class were
capable of immobilizing and opsonizing C. fetus sub sp fetus and appearance correlated
with early clearance of organisms from the uterus. In the vagina, immunoglobulins of
the classes IgM, IgG and IgA simultaneously appear when organisms undergo antigenic
variation. 19A was thought to block IgG from opsonizing organisms, keeping them from
being entirely cleared from the vaginaY Immobilizing but non-opsonic IgA in the vagina
3coupled with antigenic variation permits persistence of organisms in the vagina but
prevents uterine colonization because of uterine IgG opsonins. The resulting continuous
antigenic stimulus keeps protective antibody levels high. lO. 1l
The antibody response to T. foetus appears to differ from that of
Campylobacter fetus. Skirrow and BonDurant2R showed that natural antibodies to T.
foetus present in bovine serum are responsible for preinfection reactivity against T.
foetus. It was shown that T. foetus cross-reacted with C. fetus and trauma,
contamination and inflammation from collection procedures may stimulate both local
production ofcross-reactive antibodies and the infiltration of systemic antibodies into the
reproductive tract. IgG and IgA were the predominant immunoglobulins in the
reproductive tract. They also showed marked fluctuations in immunoglobulins following
the initial response to T. foetus. This phenomenon has also been shown with
campylobacteriosis and brucellosis, and may be attributed to the fact that reproductive
secretions are intrinsically cyclical in na ture. 28
An early study done by Pierce25 reported that an agglutinin to T. foetus develops
in vaginal discharges of infected animals. The appearance of the agglutinin coincides
with the disappearance ofthe active organism. There is a reduction in concentration of
the agglutinin in the vaginal mucus when estrus returns or a uterine discharge is
present. This is associated with the reappearance of active organisms.
Mucus is produced primarily by cervical goblet cells and the amount produced
varies throughout the estrous cyde. 21l Postestrual hemorrhage can expose the tract to
serum components through leakage from congested endometrial capillaries. The
predominant immunoglobulin in the mucus secretions was IgG 1, and radioimmunoassay
showed that it appears to predominate in the secretions of the respiratory, alimentary
4and genital tracts ofcattle.13 It was suggested that only a small proportion. of the isotype
IgG l were derived from the plasma, and remainder synthesized locally by mucosal
lymphoid cells found in the lamina propria and at the base of the villi. 1:1 A study done by
Sow et al,. demonstrated IgG2 as the predominant serum antibody, while those isolated
from vaginal mucus were chaxacterized as IgGJ .10
Other important immwloglobulins in the reproductive tract are IgM and IgA. 19A
is a minor serum component but a predominant immunoglobulin in nasal secretions,
tears and saliva; its relative concentration in vaginal mucus is lower than IgG but higher
proportionally than in serum.4.14
BonDurant et az3 immunized virgin cowsCheifers) with immunoaffinity-purified
Tritrichonwnas foetus antigen in incomplete Freund's adjuvant. They showed clearance
of infection faster than with adjuvant controls. lsotype-specific enzyme-linked
immunosorbent assay showed serum IgG1 and IgG2 antibody responses along with
cervicovaginal mucus IgG land IgA antibodies peaked about the time of clearance of
infection in vaccinated animals. Control cattle developed cervicovaginal mucus IgA
antibody responses as expected with a primary local immune response. This study
showed the importance of eady clearance of the T. foetu.s organism as uterine infection
persisting beyond 7 weeks result in endometl'itis, placentitis, or fetalloss,:":!:! Another
study done by Gault et a[17, provided similar results by showing vaccine efficacy to T.
foetus infection is attributable to systemic immunization, leading to enhanced localized
immune response.
Parsonsen et a[24 saw no placental or genital lesions prior to 7 weeks and fetal
loss did not occur until 9 weeks into experimental infections with T. foetus. Thus,
pregnancies would be less likely to· be adversely affected if heifers or cows clear
5infections within 7 weeks. Infertility can be prevented by protection from cen'icitis,
endometritis, placentitis, and/or embryonic death, so that reproductive failure should be
prevented by herd immunity if all cows aloe vaccinated.-1 Immunization has also proven
to be effective in curing the cervicovaginal carrier state in venereal vibriosis. 26
CHAPTER II
Seroconversions in Cattle Vaccinated with Tritrichomonas foetus
The purpose ofExpel"iment I was to develop a simplified serologic test to measure
seroconversion in cattle vaccinated with a T. foetus vaccine. The intent was to monitor
seroconversion in vaccinated cattle, but the feasibility of detecting anti-To foetus
antibodies in naturally infected animals was also examined. An objectively quantitative
fluorescent immunoassay system (FlAX IOOnl fluorometer, Bio-Whittaker Inc.,
Walkersville, Maryland) was chosen for this purpose. Tests using FlAX technology have
been reported to be rapid and economical, to be easy to adapt to many types of parasites,
to provide reasonable precise estimates of antibody levels and to have the flexibility to
detect IgG, IgM or other antibody classes. 16
MATERIALS AND METHODS
Animals: Four one-year-old virgin Hereford-Angus heifers were pUl"chased from a single
herd in Oklahoma. They were grouped together in an isolation paddock and fed hay,
grain and water ad libitum. Three of the heifers were vaccinated with the Fort Dodge
vaccine and one served as a non-vaccinated control. Vaccine wa~ given in two doses two
weeks apart consistent with manufacturer recommendations. Blood samples were
drawn from each heifer on a weekly basis for approximately 11 weeks.
Reference Sera and Vaccine: Reference sera collected during a previous cattle
vaccination study and slide IFA titers were obtained from l'esearchers at the University
Nevada-Reno, Reno, NV (Drs. M. Hall and W.G. Kvasnicka, School of Veterinary
Medicine). The Trichomonas Foetus VaccineTI1 was provided by Fort Dodge Laboratories,
Fort Dodge, Kansas, and consisted of formalin-fixed whole cells in oil adjuvant.
Organisms: AT. foetus 2 ! isolate was cultured in modified Diamond's medium. Modified
6
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media consisted of 10.0 ml of Diamond's medium without agar to which was added 1.5
ml bovine serum and 0.2 ml ofan antibiotic solution containing 1,000 Units of Penicillin
and 50 pg of Streptomycin to inhibit bacterial growth. Tritrichomonas foetus were
aseptically transferred every 4 days in 0.5 ml volumes to fresh media. The cultures were
incubated at 37 C and harvested at peak growth phase.
Antigen Preparation: At peak growth, the T. foetus cultures were placed in a
refrigerator at 4 C overnight to allow the organisms to settle to the bottom of the tube.
The seWed cultures were centrifuged at 2000 x g for 10 minutes, and the supernatant
extracted from the tube using a vacuum pump. The T. foetus pellets were transferred
to graduated conical centrifuge tubes and resuspended with physiological saline to 15.0
ml. The resuspended material was centrifuged for 10 minutes at 2000 x g and the
supernatant again removed. The latter process was repeated twice to remove excess
media. After the final wash, the pellet of whole organisms was resuspended in 1.0 ml
of physiological saline and frozen at -20 C.
Fluorometric Assay: The antigen consisting of freeze-tlla wed whole cells was ti tratcd
against positive control sera to determine the optimum working concentration. Whole-
cell T. foetus antigen was diluted by serial 2-fold dilutions, spotted in 25 J.lI amounts onto
cellulosenitrate disks attached to StiQT:VI samplers (Bio-Whittaker Inc., Walkersville,
Maryland) and allowed to dry overnight. The StiQsT:c1 with adsorbed antigen were
transferred through diluted serum (25 min), a wash buffer <5 min), fluorescein
isothiocyanate (FITC)-conjugated rabbit antibovine IgG (15 min), and a final wash (5
min). Sera were tested in 1.0 ml aliquots at a dilution of 1: 100 in phosphate-buffered
saline at pH 7.3 and containing 0.15% polyoxyethylene sOl"bitan monolaurate (Tween 20).
The washes were done in 0.6 ml volumes of buffer and the conjugate was diluted 1:200
8and used in 0.5 ml aliquots. Tween 20 buffer was used as diluent in all steps and all
samples were tested in duplicate at room temperature.
Antibody binding was determined by measming the amount of fluorescence
produced by the bound FITC-conjugated antibovine IgG. A FlAX lOOn! fluorometer was
used to measure the fluorescence on the StiQ samplers. The flUOl"Ometer measured
fluorescence at a wavelength of 540 urn when excited by light of 475 nm. 1ii Antibody
levels were compared to positive and negative sera selected from a series of test sera
collected from one of the OSU vaccinated heifers. The positive control produced the
highest fluorescent readings (comparable to ELISA optical density readings) and the
negative control the lowest for that animal. Antibody levels for the samples were
expressed as FlAX values; FlAX values are rankings and not absolute expressions of
titer. FlAX values were extrapolated from regression curves based on log-log data
conversions ofthe StiQ fluorescence measured for duplicate controls in each test and the
assigned standard FlAX values for the negative and positive controls. Standard FLAX
values were arbitrarily assi.gned to the control sera to provide a scale for ranking
samples according to antibody levels of all other tested sera. The extrapolated FlAX
values for all samples were paired means.
Statistical Analysis: FlAX values representative of negative, suspect and positive
antibody levels were estimated from the extrapolated FlAX values. The mean and
standard deviation for all prevaccination samples and the control animal samples were
used to calculate the upper value for negative sera using a 95% confidence limit (mean
+ 1.96 x SD); values greater than the calculated value were considered positive. A Systat
statistical program (Systat, Evanston, Illinois) was used to construct probability plots,
quantile plots and stem and leaf plots and to compute statistics on the data. The suspect
9or transitional range was derived fl"Om a SYSTAT stem and leaf plot of the entire set of
data; values between the upper hinge (75th percentile) and the calculated upper limit
for negative sera were designated suspect. Quantile and pl"obability plots were used to
visually verify the point at which FlAX values deviated from the normal distribution of
the negative range.
RESULTS
Control sera wem chosen from one of the vaccinated heifers to provide a scale to
rank serum antibody levels. The negative contml was assigned a FlAX value of 25 and
the positive control 200; all other sera were ranked with regard to the controls.
Figure 1 shows a frequency distribution of FlAX values of all OSU sera. Visual
inspection oftms graph and the quantile and probability plots (not shown) indicated that
seroconversion occurred at FIAX values of approximately 60. A Systat stem and leaf plot
of the data indicated that FIAX values greater than 74 were designated "outside values"
or what could be considered seropositive. FlAX values higher than 72 were excluded
and statistics were calculated for the remaining data. The mean (46.67) was added to
1.96 times the standard deviation (=25.40) to estimate the highest
nonpositive value (72.07). Therefore, FIAX values between 56 (the upper hinge of a stem
and leaf plot) and 72 (the highest calculated negative value) were designated to
represent the suspect range.
Figure 2 shows the IgG response curve for the OSU cattle vaccinated with the T.
foetus vaccine. The highest FlAX value (lgG level) in a vaccinated cow was 237. FlAX
values for the negative control animal ranged between 28 and 55. Figure 3 shows that
the FlAX values for 20 selected bovine reference sera obtained from a Reno vaccine trial
were similar to those in the OSU study. By the second week postvaccination, all animals
10
exhibited a dramatic increase in IgG antibody levels. The highest FlAX value observed
in the Reno sera was 193 and IgG antibody apparently remained near that level for
several weeks. To convert FlAX values to titers, a regression analysis was performed
using the FlAX values generated in the OSU study and the slide IFA titers of the Reno
reference sera. Table 1 shows the regression results indicating that the highest FlAX
value of 193 was approximately equivalent to an estimated IFA titer of 7732.
Figure 1. Frequency distribution of FlAX values for control and vaccinated cattle
included in the OSU vaccination trial. The minimum positive value was
calculated from the mean and standard deviation using a 95% confidence
limit
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Table 1. Regression estimated IFA titers for 20 reference serum samples from a Reno
vaccine trial estimated from FlAX values and the corresponding slide IFA
titers for individual samples.
FIAX value Slide IFA titer Estimated IFA titer l
9 200 0
19 200 0
27 200 0
29 200 0
34 200 0
37 200 0
45 200 336
55 200 835
93 2000 2735
98 2000 2984
98 2000 2984
112 2000 3684
133 2000 4734
133 2000 4734
144 2000 5283
155 2000 5833
156 10000 5883
162 10000 6183
186 10000 7382
193 10000 7732
lNegative estimated values listed as 0
CHAPTER III
Challenge infections in cattle with single or double vaccinations with
TritrichQmonas foetus vaccine
Animals from Experiment I were included in a second vaccination experiment a
year later to determine if the twice-vaccinated heifers would clear challenge infections
with Tritrichonwnas foetus differently than single-vaccina tion animals. Cervico-vaginal
mucus samples were also obtained to measure IgG antibody.
MATERIALS AND METHODS
Experiment II
Animals: The four initial heifers from Experiment I (now two years old) were retained
for one year for a second vaccination study. Fow: additional one-year-old virgin Hereford
Angus heifers were purchased from a single herd in Oklahoma. One two-year-old and
one one-year-old heifer served as negative controls. All animals were housed together
in an isolation paddock and fed hay, grain and water ad libitum. There were three
groups of cattle. Group I consisted of three previously vaccinated heifers (from
Experiment 1); Group II included three unvaccinated animals; and Group III consisted
of two unvaccinated controls. Group II heifers were challenged in the same fashion as
Group I. Both Group I and II heifers were vaccinated with the same whole cell Fort
Dodge T. foe.tus vaccine used in Expeliment I. Vaccine was administered consistent with
manufacturer recommendations (see Chapter II).
Antif:en for serologic tests: Antigen was prepared as described in Chapter II.
Blood sample collection: Approximately 10.0 cc of blood was drawn from the jugular
vein into serum vacutainer tubes of each heifer on a weekly basis for approximately 17
18
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weeks for Group I heifers and 13 weeks for Group II heifers. Negative controls were
sampled with their respective age groups.
Cervico-vaginal mucus collection: Cervical fluid samples were taken from each
heifer on a weekly basis for approximately 13 weeks. Cervico-vaginal mucus samples
from Group I and Group II animals were collected post-exposure to T. foetus. To obtain
cervical samples, the external vaginal area was cleaned with diluted Nolvasan solution
prior to collection. A sterile artificial insemination pipette was used to aspirate the
sample. The sterile pipette within its protective plastic sleeve was guided through the
vulva to the fornix of the cervix with the left hand, while the fornix was stabilized with
the right hand per rectum. When in place, the pipette tip was then pushed through the
plastic sleeve. A 35 cc syringe was placed on the end of the pipette and negative
pressure applied to aspirate the cervical fluid. The pipette was then pulled back into
the sleeve and both withdrawn from the vagina. The cervico-vaginal mucus sample was
then placed in 1 ml of sterile 0.9% saline.
FluQrometric assay: Serum antibody assay was described in Chapter II. The
fluorometric assay for the cervical wash samples was conducted in a ijimilar manner as
for the serum samples. Cervical wash samples were diluted 1:1 with sterile 0.9% saline.
The samples were tested in 1.0 rol aliquots at a dilution of 1:18 in phosphate-buffered
saline at pH 7.3 and containing 0.15% polyoxyethylene sorbitan monolaurate (Tween 20).
The washes were done in 0.6 ml volumes of buffer and the conjugate was diluted 1:300
and used in 0.5 ml aliquots. Tween 20 buffer was used as diluent in all steps and all
samples were tested in duplicate at room temperature.
The antibody concentrations were determined in the same manner as previously
described in the Fluorornetric Assay section of Chapter II using the positive serum
20
samples as controls, and antibody concentration was expressed as FlAX values.
Inoculation of T. foetus organisms; AT. foetus 21 isolate was cultured as described in
Chapter II. At peak growth phase a sterile artificial insemination(AD pipette was used
to inoculate approximately 7.0 x 106 organisms/ml near the cervix of all eight virgin
heifers (vaccinates and controls). This procedure was done twice in Group II animals,
with a one week interval between inoculations. Once the heifers were inoculated, weekly
samples ofcervico-vaginal mucus were taken. A direct smear was examined by placing
a drop of the mucus sample with a drop of normal saline on a slide. A sample was
considered positive if T. foetus organisms were seen. When a direct smear sample was
found to be negative, the cervical wash material was then cultured in Diamond's media
as described in Chapter II. The samples were observed microscopically at 24, 48, 72, or
96 hours for the presence of organisms. A heifer was considered cleared of the T. foetus
organism when three consecutive cervical fluid cultures were negative.
RESULTS
Control seTa from Experiment I were used to provide a scale to rank serum and
cervical fluid antibody levels. The negative serum control had a FlAX value of25 and
the positive control 200; all sera and cervical fluids were ranked with regard to the
serum controls.
Figures 4-7 show specific IgG levels in serum and cervico-vaginal fluid in the
second year vaccinate cattle(Group I). This study ran for 17 weeks. There were no
serum FlAX. values in Fig. 4 after week 10 because this heifer (#337) cleared the T.
foetus infection and no other cervico-vaginal samples were taken after that time. There
were no FlAX values in Fig. 5 and 7 after week 14 due to sample loss.
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The negative control for the single-vaccinated group was negative on direct smear
by two weeks post-challenge with T. foetus (Table III). This is in contrast to the negative
control animal for the double-vaccinated group, which did not become negative on direct
smear until four weeks post-challenge (Table II). The single-vaccinate animal (# KG4)
had elevated IgG levels in the serum prior to challenge. Tables 2-5 show the direct
smear and culture results from Group I and Group II heifers. The ca ttle were inoculated
with Tritriclwmonas foetus at week zero and week one. All cattle became infected with
the organism. By week 6 all vaccinated and control cattle became negative on direct
smear, and samples were routinely cultured on Diamond's media. Only twice-vaccinated
heifer #337 from Group I was culture negative by week 8, whereas the remaining heifers
were culture positive to the end of the observation period 03-17 weeks).
Figures 8-11 show specific IgG levels in serum and cervico-vaginal fluid in the
first year vaccinate cattle(Group II). This study ran for 13 weeks. The highest recorded
serum FlAX value(IgG level) in Group I was 225, and the highest serum value in Group
II was 275. The FIAX serum values for the negative control animal from Group I ranged
between 15 and 75, and the serum values from Group II between 50 and 120. By the
second week post-vaccination, all animals exhibited increased serum IgG levels.
The highest cervical fluidi FlAX valueOgG level) in Group I was 75, and the
highest cervical fluid value in Group II was 78. The FlAX cervical fluid values for the
negative control animal from Group I ranged between 1 and 25, and the cervical fluid
values from Group II between 0 and 15. Because the cervico-vaginal fluid was tested
5 times more concentrated, the specific IgG in the vagina was much lower than in serum.
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FIAX tests we.re run on each serum and cervico-vaginal fluid sample at least four
times with the respective serum sample. Specific IgG antibody was found in the cervical
fluid samples. FlAX values oflgG antibodies for cervical fluid samples were significantly
lower than for serum samples.
Figure 4. Specific IgG levels in serum and cervico-vaginal fluid in second year
vaccinate heifer (337) vaccinated with Tritrichomonas foetus vaccine.
Arrow denotes challenge with T. foetus organism. Dottedline represents
minimum FLAX value.
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Figure 5. Specific IgG levels in serum and cervico-vaginal fluid in second year
vaccinate heifer (343) vaccinated with Tritrichomonas foetus vaccine.
Arrow denotes challenge with T. foetus organism. Dotted line represents
minimum FlAX value.
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Figure 6. Specific IgG levels in serum and cervico-vaginal fluid in second year
vaccinate heifer (347) vaccinated with Tritrichomonas foetus vaccine.
Arrow denotes challenge with T. foetus organism. Dotted line represents
minimum FlAX value.
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Figure 7. Specific IgG levels in serum and cervico-vaginal fluid in non-vaccinated
control heifer (355). Arrow denotes challenge with T. foetus organism.
Dotted line represents minimum FlAX value.
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Figure 8. Specific IgG levels in serum and cervico-vaginal fluid in first year
vaccinate heifer (KG1) vaccinated with Tritrichomonas foetus vaccine.
Arrow denotes challenge with T. foetus organism. Dotted line repl-esents
minimum FlAX value.
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Figure 9'. Specific IgG levels in serum and cervico-vaginal fluid in first year
vaccinate heifer (KG2) vaccinated with Tritrichonwnas foetus vaccine.
Arrow denotes challenge with T. foetus organism. Dotted line represents
minimum FlAX value.
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Figure 10. Specific IgG levels in serum· and cervico-vaginal fluid in first year
vaccinate heifer (KG3) vaccinated with Tritrichomonas foetus vaccine.
Arrow denotes challenge with T. foetus organism. Dotted line represents
minimum FlAX value.
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Figure 11. Specific IgG levels in serum and cervico-vaginal fluid in non-vaccinated
control (KG4). Arrow denotes challenge with T. foetus organism. Dotted
line represents minimum FlAX value.
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TABLE II
Tritrichomonas foetus detected in direct smears of vaginal wash samples of
cattle challenged with T. foetus after repeated vaccination
Sample
Time
Double
Vaccinate
(337)
Double
Vaccinate
(343)
Double
Vaccinate
(347)
Negative
Control
(355)
WeekI challenge challenge challenge challenge
Week 2 + + + +
Week 3 + -8 +
Week 4 +
Week 5 +
Week 6
8Negative samples were put in Diamond's media for culture
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TABLE III
Tritrichomonas foetus detected in direct smears of vaginal wash samples of
cattle challenged with T. foetus after initial vaccination
SingleR Single Single Negative
Sample Vaccinate Vaccinate Vaccinate Control
Time (KGl) (KG2) (KG3) (KG4)
Week 1 challenge challenge challenge challenge
Week 2 + + + +
Week 3 + b
Week 4 +
Week 5
aSingle vaccination means vaccinated once 2 weeks prior to challenge.
bNegative samples were put in Diamond's media for culture.
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TABLE IV
Culture results for vaginal washings, checked at 24, 48, 72 or 96 hours, for
cattle repeatedly vaccinated with Tritrichomonas foetus vaccine
Sample
Time
Double
Vaccinate
(337)
24487296
Double
Vaccinate
(343)
24487296
Double
Vaccinate
(347)
24487296
Negative
Control
(355)
24487296
Week 3 a + + a-
Week 4 + + + a
Week 5 + + + a
Week 6 + + +
Week 7 + b +
Week 8 h + h
Week 9 CLEARED + + +
Week 10 CLEARED + + +
Week 11 CLEARED + + +
Week 12 CLEARED + + +
Week 13 CLEARED b + + +
Week 14 CLEARED + + +
aSamples not cultured because of positive direct smear results.
"Samples contaminated with fungus.
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TABLE V
Culture results for vaginal washings, checked at 24, 48, 72 or 96 hours, for
cattle singly-vaccinated with Tritrichomonas foetus vaccine
Double Double Double Negative
Sample Vaccinate Vaccinate Vaccinate Control
Time (KGl) (KG2) (KG3) (KG4)
24 48 72 96 2448 7296 244872 96 244872 96
Week 3 a + + +
Week 4 III + + +
Week 5 + + + +
Week 6 + + + +
Week 7 + + + +
WeekS + + + +
Week 9 + + + +
aSamples were not cultured because of positive direct smear results
DISCUSSION
The FlAX test was rapid, economical, easy to perform, and it was quickilly and
easily adapted for T. foetus tests using freeze-thawed whole-ceH organisms as antigen.
Other workers have used FlAX. serology to detect IgG antibody to Sarcocystis cruzi l5 ,
Cytauxzoon felis l2 and many other parasites16 . This was the first FlAX test developed
to fluorometrically detect IgG antibodies to Tritrichomonas foetus in serum and cervical
exudates.
FlAX detected seroconversion in the Oklahoma State University (OSU) cattle
within two weeks after giving the initial dose of the Fort Dodge T. foetus vaccine, and
FlAX values increased for the next 5-6 weeks (Fig. 2). SimHar response curves were
found with reference sera obtained from an outside vaccine trial (Fig. 3). When FlAX
values were regressed against previously determined reciprocal titers for the reference
sera it was found that IFA titers were estimated as high as 7700 (Table 1).
Similar response curves and antibody titers were observed in both the in-house
and Reno vaccine trials (see Chapter II). Seroconversion was apparent within 1 to 2
weeks following the initial inoculation (Fig 2). This was slightly earlier than could be
detected using visual evaluation of slide IFA tests. The subjective visual estimates of
antibody levels using IFA titers are inherently inaccurate at high titers because of the
two-fold dilution schemes. Better titer estimates for comparative purposes would be
obtained using more sensitive ELISA titers. The FlAX values could be converted to
ELISA titers in the same manner as for the IFA titers herein reported.
Elevated IgG was apparent in one animal within one week of giving the vaccine,
although not at a statistically significant level. However, IgG levels for all double-
vaccinates increased significantly by the second week following initial administration
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of the vaccine. At two weeks post-vaccination, the average estimated IFA titers had
increased to approximately 2800. All three of the double-vaccinated OSU heifers
developed titers that peaked between 7 and 10 weeks and fluctuated at high levels for
up to 10 weeks. Response curves (Figs. 2 and 3) show the Fort Dodge vaccine was
effective in stimulating strong IgG antibody responses in heifers.
This was the first time a FIAX test has been used to detect IgG antibody levels
in serum and cervico-vaginal fluid in cattle challenged with Tritrichomonas foetus
organisms. This study is also the flrst to compare the clearance of T. foetus in cattle
challenged with the organism that have been vaccinated for two consecutive years
against the clearance rate in cattle that have been vaccinated just once.
Seroconversion was detected in all single-vaccinated cattle within two weeks
following vaccination with the Fort Dodge T. foetus vaccine. IgG antibody levels were
detected in cervico-vaginal fluid between 4 and 5 weeks post-vaccination, at lower levels
than in serum (Fig 4-11). There are no IgG level values in Figure 5 and 7 after week 14
due to loss ofsamples. Levels of IgG increased for two weeks following vaccination then
began to decrease. IgG levels in three heifers decreased dramatically by weeks 6-8 of the
study (Fig 5, 6 and 9). These same heifers showed IgG antibody increases in cervico-
vaginal fluid in contrast to the decline of IgG antibody in the serum. This finding
concurs with a study done by BonDurant et all showing peak IgG. levels in cervical
vaginal mucus was accompanied by a drop in serum levels due to "spillover" of IgG into
vaginal secretions.
Anamnestic IgG responses occurred in twice-vaccinated cattle within one week
of vaccination, and specific IgG elevated sooner than in the previous year. One heifer
(Fig 4) had IgG levels that plateaued within two weeks after vaccination and remained
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high for eight weeks then slowly declined. She cleared the T. foetus infedion by week
ten (Table 4). The other heifers (Fig 5 and 6) in this group had serum IgG levels that
started to decline sharply by week four and five, and did not clear the infection (Table
4). This may suggest that an animal that does not produce a good antibody l'esponse to
vaccine may become a carrier animal of the T. foetus organism and possibly infect herd
bulls.
The single-vaccinate negative control (Fig. 11) had elevated serum IgG levels
prior to challenge with T. foetus. This elevation in serum IgG might explain why T.
foetus numbers decreased quickly in the cervico-vaginal fluid. This animal might have
had previous exposure to T. foetus, and developed some immunity against the organism,
although this is highly unlikely. A study done by Corbeil et al9 demonstrated bovine
immunoglobulin binding to T. foetus during growth in medium which contains normal
bovine Sel"urn.. This binding of immunoglobulin by T. foetus could be a -problem in
serologic assays in which T. foetus grown in bovine serum was used as the antigen, !->ince
anti-bovine Ig conjugates would react with this antigen preparation even if the test
sample had no antibody. This cross-reactivity can also seen in ELISA tests, causing false
positive results.~o Yule et af2 observed cross-reactivity between T. foetus and bovine
cervical mucus. The other sera in this study (Fig. 4-10) did not demonstrate this problem
of cross-reactivity. This researchel' thinks this animal had a peculiar immune system,
and cross-reactivity might be a possibility. A study done by Skirrow and BonDurant21l
showed that natural antibodies to T. foetus can be responsible for preinfection reactivity
against T. foetus. Trauma, contamination and inflammation from collection of cervico-
vaginal mucus may stimulate both local production of cross-reactive antibodies and
infiJ.tration of systemic antibodies into the reproductive tract.
4.6
The twice-vaccinated negative control (Fig. 7) exhibited a seropositive response
following challenge with T. foetus. Serum IgG levels are not elevated as high as the
twice-vaccinated animals (Fig. 4-6), but the characteristics of the graphs are similar in
pattern. Both vaccinated and unvaccinated animals exhibit a seropositive response
following challenge, and IgG can be detected in the cervico-vaginal mucus. This
challenges the "spillover" theory of serum IgG passing from the systemic circulation over
into the reproductive tract. The elevated serum IgG in the twice-vaccinated negative
control is due to a local infection of the cervico-vaginal area with T. foetus. It is unclear
with the twice-vaccinated animals whether the elevation of cervico-vaginal mucus IgG
was due to a "spillover" from serum or a local immune response in the reproductive tract.
To clear up this issue, a negative control animal that is not challenged with T. foetus
could be utilized and compared to the challenged negative controL
The double and single-vaccinate direct smear results (Table II and IIl) are similar
with respect to almost all cervical mucus samples were cultured by week 3 after
challenge with T. foetus. All double-vaccinate animals (Table IV) except one remained
culture positive for T.. foetus up to week 14. All single-vaccinate animals (Table V) were
still culture positive by week 9. This suggests that direct smear results might not be
reliable beyond 2-3 weeks for detection of parasi tes.
A main aspect of this study was to determine if the twice-vaccinated cattle
cleared a T. foetus infection more quickly than single-vaccinated cattle. Organisms
initially localize in the vagina, and later move to the uterus and oviduct, but their
presence there does not prevent conception. However, the secretions in these organs
continue to contain parasites. Some cows develop an active immunity and may conceive
and carry a calf to term following three to five heat cycles after an abortion. This
_----------------------------------~~~I.U'f- ~lnn- __ __ •
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immunity, however, is not permanent or "solid" and the cow can be subject to reinfection
during later breeding periods. 19
There were six vaccinated cattle in this study, and only one cleared infection by
ten weeks into the experiment <Tables 4 and 5). The only animal that cleared the
infection was double-vaccinated. The lack of clearance in other heifers indicates T.
foetus vaccine does not elicit a protective immune l'esponse in cattle, however the twice-
vaccinated heifer that cleared infection appeared to be protected. This suggests that
vaccine response may be related to an animal's individual immune response. A study
done by BonDurant et afl featured a surface antigen of T. foetus as the basis for a
vaccine. The T. foetus surface antigen reacted with a monoclonal antibody which
immobilized and mediated complement killing of the organism and prevented adherence
to vaginal epithelial cells. This indicates that the recognized epitopes are accessible by
antibody in the living organism. The latter demonstrated clearance of T. foetus from 75%
of vaccinated heifers by week six in contrast to ten weeks for non-vaccinated controls.
Another possible explanation for the ineffectiveness of this T. foetus vaccine could
be the severity of challenge with T. foetus organisms. Previous challenge sludies,,·z2.2B.29
show a range between 7 x 106 to 2 X 107 organisms per milliliter covering both bulls and
heifers. The utilization of 1 x 107 organisms per milliliter in this experiment, although
in agreement with previous studies, could have overwhelmed this T. foetus vaccine. We
can probably assume this challenge would be more severe than a natural infection. It
would be interesting to use this vaccine in a natural field infection and compare the
results with this challenge study.
The BonDurant et al3 study suggests that vaccination is not likely to completely
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prevent colonization with T. foetus. Infertility is pl'evented by protection u'om cervicitis,
endometritis, placentitis and/or embryonic loss. Another study done by Kvasnicka et al2'2
using a polyvalent vaccine containing T. foetus, Campylobacter fetus, and Leptospira sp.
showed that immunization lowered the incidence of infection and reduced the duration
of infection. Poly-valent vaccination also demonstrated higher calving rates than non-
vaccinated controls, perhaps by protection against agents other than trichomonads.
The OSU study did not demonstrate enhanced clearance rate as with the
BonDurant3 experiment. This may be due to the difference in the T. foetus antigen
and/or adjuvant used. This is the first study using cattle vaccinated with commercial
vaccine for two consecutive years. The double-vaccinated cattle did not clear infection
faster than the single- vaccinated animals. This raises doubt that this particular T.
foetus vaccine works well in the field. Further study is ongoing with different vaccine
preparations, but it is evident that current vaccines are not adequately effective.
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